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Abstract
Background: As international travel increases, there is rising exposure to many pathogens not traditionally encountered in
the resource-rich countries of the world. Filarial infections, a great problem throughout the tropics and subtropics, are
relatively rare among travelers even to filaria-endemic regions of the world. The GeoSentinel Surveillance Network, a global
network of medicine/travel clinics, was established in 1995 to detect morbidity trends among travelers.
Principal Findings: We examined data from the GeoSentinel database to determine demographic and travel characteristics
associated with filaria acquisition and to understand the differences in clinical presentation between nonendemic visitors
and those born in filaria-endemic regions of the world. Filarial infections comprised 0.62% (n= 271) of all medical conditions
reported to the GeoSentinel Network from travelers; 37% of patients were diagnosed with Onchocerca volvulus, 25% were
infected with Loa loa, and another 25% were diagnosed with Wuchereria bancrofti. Most infections were reported from
immigrants and from those immigrants returning to their county of origin (those visiting friends and relatives); the majority
of filarial infections were acquired in sub-Saharan Africa. Among the patients who were natives of filaria-nonendemic
regions, 70.6% acquired their filarial infection with exposure greater than 1 month. Moreover, nonendemic visitors to filaria-
endemic regions were more likely to present to GeoSentinel sites with clinically symptomatic conditions compared with
those who had lifelong exposure.
Significance: Codifying the filarial infections presenting to the GeoSentinel Surveillance Network has provided insights into
the clinical differences seen among filaria-infected expatriates and those from endemic regions and demonstrated that O.
volvulus infection can be acquired with short-term travel.
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Introduction
Parasitic diseases are widespread throughout the developing
world and are associated with a heavy burden of morbidity and
mortality. Human filariae, nematodes transmitted by arthropod
vectors, are endemic in tropical and subtropical regions of the
world. With an estimated 80 million people who travel to
developing countries each year [1], exposure to filarial parasites
is likely to become more common. It has been suggested that
infection with filariae requires prolonged and intense exposure to
the vectors that transmit them [2]. Moreover, when comparing
nonendemic visitors who have acquired filarial infections with
those born in endemic regions, the nonendemic visitors appear to
have greater numbers of objective clinical symptoms and fewer
clinically asymptomatic (or subclinical) infections [3–7].
The GeoSentinel Surveillance Network, a global network of
specialized travel/tropical medicine clinics on six continents, was
established in 1995 to contribute clinician-based sentinel surveillance
on all travelers seen [8]. We examined data from the GeoSentinel
database to identify demographic and travel characteristics associ-
ated with filaria acquisition in addition to species distribution of
filarial acquisition and patient symptoms. Because there have been
no comprehensive studies that have addressed the acquisition of
filarial infections among nonendemic travelers, the present study was
performed to understand travel-related filarial infections from
a global viewpoint that could inform physicians and travelers alike.
PLoS Neglected Tropical Diseases | www.plosntds.org 1 2007 | Volume 1 | Issue 3 | e88
Methods
Data source
Demographic, travel, and clinical data were collected from all
patients seen at each GeoSentinel site. Travel information was also
collected, including trip start and end dates for travel within
6 months and countries visited in the previous 5 years. Countries
listed included birth country, country lived in prior to age 10,
country of residence, and country of citizenship. Patient classifi-
cation, the reason for recent travel, symptoms, and final diagnosis
were reported by health care providers at GeoSentinel site clinics.
Patient information was entered without identifiers into an Access
database (Microsoft). Each individual record with a diagnosis of
filarial infection was examined manually to verify that the place of
exposure was in a filaria-endemic country and that the data
provided were accurate and complete.
The GeoSentinel data-collection protocol was reviewed by the
institutional review board officer at the National Center for
Infectious Diseases at the Centers for Disease Control and
Prevention and classified as public health surveillance and not as
human-subjects research requiring submission to institutional
review boards.
Inclusion criteria
Data entered into the GeoSentinel database from patients seen
from August 1997 through December 2004 were used. This
analysis focused on data extracted from persons who were assigned
codes corresponding to infection with Onchocerca volvulus, Wuchereria
bancrofti, Loa loa, other filarial species, or unknown filarial species.
Prior to analysis, a survey of all GeoSentinel sites was performed to
ensure that the definition of infection was uniform among the
reporting sites.
Definitions and groupings
Patient classifications. Patients were classified into seven
categories: immigrants/refugees, foreign visitor, urban expatriate,
non-urban expatriate, student, traveler, military. These categories
were based on country of origin, place of GeoSentinel site visit,
and purpose of travel. An immigrant was defined as someone born
and raised in a filarial-endemic region. A traveler was defined as
one who crossed an international border and returned to his/her
country of residence and presented to a clinic site. A foreign visitor
was someone who sought medical care at a GeoSentinel site
during their trip but was not a resident or citizen of that country.
Persons who emigrated from one filaria-nonendemic country to
another filaria-nonendemic country and classified as ‘immigrant’
were reclassified to an appropriate category. Students from filaria-
endemic regions studying in nonendemic regions were reclassified
from student to immigrant for the purposes of these analyses.
Persons born and raised in filarial nonendemic regions and
traveling to filarial-endemic regions are collectively referred to as
‘‘nonendemic visitors’’.
Reason for recent travel. The reasons for recent travel were
categorized into immigration, tourism, business, research/
education, missionary/volunteer, or visiting friends or relatives
(VFR) based on patient self-report to physician. VFR are people
born and raised in a filaria-endemic region, but currently residing
in a filarial nonendemic region. Students from filaria-endemic
regions studying in nonendemic regions were reclassified from
education to immigrant for the purposes of these analyses.
Diagnoses. Physician-reported final diagnoses were assigned
a diagnosis code and entered into the GeoSentinel database.
Diagnoses are defined as suspect, probable, or confirmed.
Confirmed means that the diagnosis was made by an
indisputable clinical finding or diagnostic test (identification of
the parasite or parasite DNA), and probable indicates that the
diagnosis was supported by evidence strong enough to establish
presumption (classical clinical findings and positive serology, and
response to definitive treatment), but not proof. All sites used the
best available reference diagnostics in their own country. Some of
the ‘filarial species unknown’ diagnoses were reclassified into O.
volvulus, W. bancrofti, or L. loa if the country of exposure had only
one filarial species present. Of the 65 originally classified as
unknown filarial species, 50 were reclassified.
Regions. Countries were grouped into regions: Southeast
Asia, Eastern Europe, Northern Africa (including Canary Islands),
Oceania, Western Europe, sub-Saharan Africa, South America,
Caribbean, South Central Asia (including Tibet), Western Asia,
Australia/New Zealand, North America, Antarctica, Eastern/
North Asia (including Taiwan), and Central America.
Duration of travel, and time to presentation to a
GeoSentinel site. Detailed travel data were available for only
a subset of patients. In those for whom this information was
available, trip duration and time to presentation were divided into
1 month, 1-6 months, and over 6 months to group short, medium,
and long-term exposure and incubation periods. Those without
definitive travel data related to the place of exposure were
excluded only from this particular type of analysis. Trip duration
and time to presentation were determined only for those who did
not have lifelong exposure to filarial infections. The time to
presentation was the interval between the clinic visit and date of
return from the most recent travel to a filarial-endemic region of
the world.
Statistical analysis
Data were managed in Microsoft Access and were analyzed
using SAS v.9.1 (SAS Institute). Crude odds ratios were calculated
from a bivariate analysis, and statistical significance was de-
termined by x2 tests.
Results
From a total of 43,722 individual patient encounters, filarial
infections were diagnosed for 271 (0.62%) persons who presented
to GeoSentinel sites from August 1997 through July 2004. The
reporting of cases to GeoSentinel was lowest in 1997 and 1998
(3.7% and 8.9% respectively); from 1999 through 2004, filariasis
as a proportion of morbidity (ill patients reporting to the clinics)
Author Summary
As international travel increases, there is rising exposure to
many pathogens not traditionally encountered in the
resource-rich countries of the world. The GeoSentinel
Surveillance Network, a global network of medicine/travel
clinics, was established in 1995 to detect morbidity trends
among travelers. Filarial infections (parasitic worm infec-
tions that cause, among others, onchocerciasis [river
blindness], lymphatic filariasis [e.g. elephantiasis, lymphe-
dema, hydrocele] and loiasis [African eyeworm]) comprised
0.62% (n= 271) of the 43,722 medical conditions reported
to the GeoSentinel Network between 1995 and 2004.
Immigrants from filarial-endemic regions comprised the
group most likely to have acquired a filarial infection; sub-
Saharan Africa was the region of the world where the
majority of filarial infections were acquired. Long-term
travel (greater than 1 month) was more likely to be
associated with acquisition of one of the filarial infections
than shorter-term travel.
Filarial Infections in Travelers
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fluctuated between 11% (n=30) and 17.5% (n=47). Of the 271
patients with filarial infections, 37% were diagnosed with O.
volvulus, 25% were infected with L. loa, and another 25% were
diagnosed with W. bancrofti. Among all filarial infections, 5.5%
were identified as other filarial species, (e.g., Mansonella, Brugia
spp.), and 5.5% of all filarial infections reported in the database
were unspecified. Three patients were coinfected with L. loa and
other filarial species; one patient presented with O. volvulus and L.
loa coinfection (Figure 1). Overall, 122 (45%) patients were female;
gender was not recorded for 17 (6.3%) patients. Patient mean age
was 34.9 years (range 0–84). The region of acquisition among
filaria-infected individuals was assigned when possible (n=230).
The majority (75%) of infections were acquired in Africa (both
Northern Africa and Sub-Saharan Africa) and 10% in South
America (see Table 1). The remaining individuals were exposed in,
Oceania, the Caribbean, South Central Asia, and Central
America. Of all filarial infections reported to the GeoSentinel
ntwork (n=271), the majority were reported by the North
American sites (76.4%); 18.5% were reported from European
sites, and the remainder were reported from GeoSentinel sites in
the Middle East, Australia/New Zealand, and South Central Asia.
Among the 271 patients diagnosed with filarial infections, the
majority (62%) occurred among immigrants. Non-urban expatri-
ates and travelers represented the second largest group of patients
with filarial infections. Foreign visitors, urban expatriates, and
students (Figure 2) comprised the groups in which there were
relatively few filarial infections. As an overall proportion of
GeoSentinel reports, filarial infections were found to occur in
1.6% of immigrants, 2.4% of non-urban expatriates, 1.5% of
students, 0.2% of foreign visitors, 0.2% of urban expatriates, and
0.2% of travelers. The ‘reasons for travel’ were predominantly for
immigration or for immigrants who were VFR in endemic regions
(63%). An additional 16% of patients traveled for missionary or
volunteer activities, and the remainder traveled for tourism,
research/education, or business-related purposes (Figure 3). When
grouped by type of parasite, immigrants and VFR had the greatest
proportion of diagnosed onchocerciasis (48%) compared with
nonendemic visitors (20%). Twenty-nine percent of VFR and
immigrants with filarial infections were infected with W. bancrofti,
while only 18% of nonendemic visitors had W. bancrofti infection.
The diagnosis of L. loa was greatest among nonendemic visitors
(43%), compared with 15% of VFR and immigrants with loiasis
(Figure 4).
Travel duration was known definitively for 108 of the 271
individuals with filarial infection. Among these 108, 48 persons
originated from nonendemic regions but only 34 had recorded
travel data definitively related to the place of exposure. Trip
duration ranged from 7 days to 17.7 years (geometric mean
duration: 125 days; median duration: 87 days). The majority of
patients with O. volvulus infections had trip durations of up to
1 month (Table 2). The majority of those with L. loa infections had
traveled between 1 and 6 months, while the highest percentage of
patients with W. bancrofti infection occurred after more than
6 months of travel (and presumed exposure).
The time to presentation to a GeoSentinel site after arrival in
a filaria-nonendemic country was calculated to identify the
possible incubation period between exposure and clinical pre-
sentation in only nonendemic visitors (VFR and immigrants
excluded from this analysis). For O. volvulus infections, 67%
presented to a GeoSentinel site within 1 month of return, and
100% of those with W. bancrofti presented between 1 and
6 months. Among those with L. loa, 12% presented within the
first month of return, 77% within 1 to 6 months of return, and the
remainder at least 6 months after return. Among patients infected
with other filarial species, the majority presented within 1 month
of return. These data suggest that Onchocerca infections are more
likely to be symptomatic early in the infection compared to either
Loa loa or Wuchereria bancrofti (data not shown).
In studies done previously in loiasis [3] and onchocerciasis [4]
among limited numbers of expatriates, the data suggested that the
clinical symptoms were more pronounced (and less likely to be
asymptomatic) in travelers (temporary visitors) to filaria-endemic
regions of the world compared with those with lifelong exposure
and chronic infections [3]. To examine this issue more closely,
a comparison was made between those infections that were
clinically symptomatic and those that were clinically asymptomatic
(Table 3). Characterization of symptoms included those associated
with the following organ systems: skin, cardiac, respiratory,
gastrointestinal, genitourinary, neurologic, musculoskeletal, oph-
thalmologic, and otolaryngologic, in addition to complaints of
fatigue, fever, and psychological problems. If the patient had no
complaints or symptoms or in which filarial infection was
0 5 10 15 20 25 30 35 40
Onchocerciasis
Loiasis
Lymphatic filariasis
Loiasis/ infection with other filarial spp.
Onchocerciasis/ Loiasis
Infection with other filarial spp.
Filarial infection unspecified
Percent
Figure 1. Distribution of filarial infections among international travelers reported in the GeoSentinel Surveillance Network.
doi:10.1371/journal.pntd.0000088.g001
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identified incidentally following evaluation for another condition,
then asymptomatic was recorded. As seen, those individuals in the
GeoSentinel database identified to have filarial infection who were
born and raised in endemic regions were 2.5 times as likely to be
clinically asymptomatic (CI 1.07, –5.93) compared with those who
traveled from filaria-nonendemic to filaria-endemic regions
(P,.03)
Discussion
While filarial infection and disease are most frequently
diagnosed among native residents of endemic regions, the risk of
infection acquisition among travelers from nonendemic regions is
sizeable. Filarial species are found in tropical and sub-tropical
regions of the world and, as travel to these regions becomes more
popular, filarial infection among nonendemic visitors becomes
increasingly common as well. We describe here important
epidemiologic characteristics of filarial infections acquired by
world travelers from nonendemic regions as reported to the
GeoSentinel network. While clinical presentation of filarial disease
is known to differ between visitors to and natives of endemic
regions [3], our analysis also provides a quantitative assessment of
filarial acquisition among travelers and helps describe the
differences in clinical presentation between those native to
filaria-endemic regions and those traveling to those regions.
Filarial infections comprised 271 cases (0.62%) of all medical
conditions reported to the GeoSentinel network. O. volvulus was
responsible for the greatest number of filarial infections (n=101),
followed by equal numbers (n=68) of L. loa and W. bancrofti
(Figure 1). Because the GeoSentinel database includes immi-
grants/refugees who undergo laboratory screening that includes
filarial serologies when eosinophilia or clinical signs or symptoms
of filarial disease are present, it is not surprising that the majority
of filaria-infected patients in the GeoSentinel network were
immigrants (62%). Due to lifelong chronic exposure, the
prevalence of filarial infections among immigrants can be
significant.
It has, however, typically been said that infection acquisition is
low for short-term, nonendemic travelers. Although travel in-
formation was only available for a subset of the total number of
filaria-nonendemic visitors, it was still unexpected to find that
almost one-third (30%) of travelers from nonendemic regions
acquired their filarial infections during trips of 31 days or less (the
majority of O. volvulus infections), and only 38% of filarial
infections occurred from trip durations exceeding 180 days
(Table 2). There are numerous case reports and case series that
describe durations of exposure as short as 10 days among filaria-
infected patients from nonendemic regions [5,9–12]. It is possible
that the lack of preventive measures such as insect repellent and
bednets, as well as individuals close proximity to vector habitats,
played a role in infection acquisition regardless of short durations
of exposure. Further, development of symptoms may also be
dependent on the density of filarial larval inoculation as well as
individual innate immune responses [13].
Because almost all of the major filarial infections (O. volvulus, W.
bancrofti, L. loa, M. perstans, M. streptocerca) are endemic in sub-
Saharan Africa, it is not surprising that 72% of filarial infections
reported to GeoSentinel were acquired in this region: 95.5% of
those with onchocerciasis were acquired in sub-Saharan Africa;
three were acquired elsewhere. Thirty-two percent of the W.
bancrofti infections were acquired in South America, compared
with only 12% of W. bancrofti infections reported from sub-Saharan
African regions, 22% from South Central Asia, and 14% from the
Caribbean. As expected, 100% of loiasis cases were acquired in
Table 1. Region and countries of exposure to filarial parasite
Region Country N (%)
Africa 172 (75.1%)
Benin 2
Burkina Faso 3
Burundi 1
Cameroon 62
Central African Republic 6
Comoros 1
Congo 5
Cote d’Ivoire 3
Egypt 1
Ethiopia 9
Gabon 7
Ghana 9
Guinea 2
Liberia 11
Nigeria 10
Senegal 1
Sierra Leone 10
Tanzania 1
Niger 2
Sudan 4
Togo 1
Uganda 1
Unspecified 18
Zaire 2
South America 23 (10%)
Brazil 1
Guyana 22
South Central Asia 15 (6.6%)
Bangladesh 1
India 8
Nepal 1
Sri Lanka 5
Caribbean 8 (3.5%)
Dominican Republic 2
Haiti 6
South East Asia 5 (2.2%)
Philippines 3
Vietnam 2
Oceania 4 (1.7%)
Guam 1
Papua New Guinea 1
Samoa 1
South Pacific Islands 1
Central America 2 (0.9%)
Mexico 1
Nicaragua 1
Total 229 (100%)
doi:10.1371/journal.pntd.0000088.t001
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West and Central Africa, as the parasite is endemic only in this
region.
While short-term nonendemic visitors appear less likely to
acquire filarial infections, among those with relatively long-term
exposure there have been many case reports of travel-related
filarial infections and associated clinical symptoms [3–5,11,13–15].
Presentation of clinical disease among patients with L. loa, O.
volvulus, and W. bancrofti differs considerably between expatriates
(or long-term temporary residents) and those born in filaria-
endemic regions of the world. Among those infected with L. loa,
infected expatriates typically have a greater frequency of Calabar
swellings, higher grade levels of filaria-specific antibody and
peripheral eosinophil counts, and more nonspecific complaints,
while those born and raised in endemic regions are more likely to
have asymptomatic infections associated with microfilaremia.
Those born in regions with endemic O. volvulus infection generally
have higher levels of skin microfilariae and more ocular disease
than do nonendemic visitors to these regions [16]. Those living in
regions with endemic lymphatic filariasis most commonly have
asymptomatic (or subclinical) infections, although significant
proportions of infected individuals develop hydrocele, lymphe-
dema elephantiasis, or chyluria. Nonendemic visitors (and short-
term visitors) rarely have asymptomatic microfilaremic condition,
but rather are more likely to develop lymphadenitis, hepatomeg-
aly, splenomegaly and reversible lymphedema [17].
This study corroborates many of the anecdotal reports about the
differences between the clinical presentations among travelers
compared with those with chronic (and often lifelong) exposure to
filarial parasites. Case report findings describe the clinical
manifestations of filarial disease to be greater among expatriates,
Visiting friends/  
relatives 19%
Immigration 44%
Tourism 9%
Business 6%
Research/ 
education 6%
Missionary/
volunteer 16%
Figure 2. Patient classification among persons with filarial infections reported in the GeoSentinel Surveillance Network.
doi:10.1371/journal.pntd.0000088.g002
Traveler 13%
Student 2%
Nonurban expat 
13%
Urban expat 3%
Foreign visitor 7%
Immigrant/
refugee 62%
Figure 3. Reason for travel among persons with filarial infections reported in the GeoSentinel Surveillance Network.
doi:10.1371/journal.pntd.0000088.g003
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while those from filaria-endemic regions present commonly
without symptoms. Indeed, our results from the GeoSentinel
network indicate that filaria-infected patients with long-term
exposure to filariae were more commonly asymptomatic (or
subclinical) compared with those expatriates with filarial infec-
tions.
With the collection of surveillance data on travel-related
medical conditions by the GeoSentinel network, epidemiologic
data can describe morbidity and mortality trends among travelers
[18]. While these networks are generally used to follow acute
infections among nonendemic visitors, we have demonstrated here
the utility of surveillance for chronic infections, as well. Diagnoses
of filarial infections in industrialized countries will likely continue
to rise as increasing numbers of people travel to endemic regions
and as increasing numbers of refugees and immigrants arrive from
endemic areas. The majority of nonendemic filaria-infected
visitors (64.7%) presented to a GeoSentinel site clinic between 1
and 6 months after return of travel, underscoring the need for
surveillance of chronic infections to ensure safety and treatment of
returning travelers from developing regions.
In conclusion, analysis of data on filarial infections available
from the GeoSentinel network enabled us to describe character-
istics of patients presenting with filarial infection and to determine
that filarial infections can be acquired with relatively short-term
exposure. Our study not only corroborates but expands the
understanding of the differences in filarial disease manifestation
between those traveling to and those born in filaria-endemic
regions of the world by providing a quantitative analysis of filarial
acquisition among nonendemic visitors. Moreover, our data
demonstrate that globally acquired travel data can be used to
follow not only acute but also chronic infections and can ultimately
provide a more comprehensive backdrop to pre-travel advice and
to post-travel treatment for those at risk of acquiring a filarial
infection.
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Figure 4. Regional distribution of filarial infections among immigrants, VFR, and nonendemic visitors reported in the GeoSentinel
Surveillance Network.
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Table 2. Trip duration by filarial infection among
nonendemic visitors
# Days
O. volvulus n
(%)
W. bancrofti n
(%)
L. loa n
(%)
Other filarial
spp. n (%)
0–31 7 (77.8) 0 2 (12.5) 1 (14.3)
32–180 1 (11.1) 0 9 (56.3) 1 (14.3)
.180 1 (11.1) 2 (100) 5 (31.2) 5 (71.4)
doi:10.1371/journal.pntd.0000088.t002
Table 3. Association between patient endemicity status and
commonly presenting symptoms of filarial infections
Symptomatic Endemic Nonendemic Total
No 35 7 42
Yes 152 75 227
Total 187 82 269
Missing: 2
OR (95% CI) 2.5 (1.05, 5.81)
doi:10.1371/journal.pntd.0000088.t003
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